2023 Full-Year reported sales growth of 6.5% to $85.2 Billion with operational growth of 7.4%* and adjusted operational growth of 5.9%*. Operational growth excluding COVID-19 Vaccine of 9.0%* 2023 Full-Year EPS of $5.20 decreasing 15.3% due to a special one-time charge in the First-Quar...
AHC MEDIAHospital Employee Health
He called it "irreconcilable with decades of independent scientific evaluations confirming Johnson & Johnson's baby powder is safe, does not contain asbestos and does not cause cancer." Haas added that J&J will not pay the verdict award while the bankruptcy proceeding continues, and "the decision ...
VOD Recordings What The Tech: Tariffs and iPhone Prices Updated: Apr. 10, 2025 at 6:16 AM GMT+8 A wave of “panic buying” is happening as people worry about potential price hikes due to ongoing trade tariffs between the US and China. VOD Recordings Ann Marie Creed named new University...
$499 million in the third quarter of 2023 compared to an expense of $226 million in the third quarter of 2022. This was primarily driven by higher unrealized mark-to-market losses on public securities, partially offset by the lower COVID-19 vaccine-related exit costs and lower litigation ...
As federal health agencies end their recommended pause on use of Johnson and Johnson's COVID-19 vaccine, CBS News chief medical correspondent Dr. Jon LaPook joins "CBS This Morning: Saturday" to answer questions about the vaccine and progr
Johnson & Johnson said on Wednesday it is working on developing a vaccine for the new coronavirus that has killed more than 100 people in China. Article content The company also said it was donating its HIV drug Prezcobix to China for use in research to find a solution against the outbreak...
The CDC is lifting its pause on Johnson & Johnson vaccines after a nearly 10-day pause due to concerns about blood clots. New vaccines will come with an FDA warning. Johns Hopkins International Vaccine Access Center executive director Dr. Bill Moss j
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the nation on the cusp of adding an easier-to-use option to fight the pandemic.